Panavir rectal suppositories 200mcg x 5pcs

Panavir® is a purified extract of the shoots of the Solanum tuberosum plant; its main active ingredient is a hexose glycoside consisting of glucose, rhamnose, arabinose, mannose, xylose, galactose, and uronic acids.
Panavir® is an antiviral and immunomodulatory agent. It increases the body's nonspecific resistance to various infections and promotes the induction of alpha and gamma interferons by blood leukocytes.
At therapeutic doses, the drug is well tolerated.
Testing has shown no mutagenic, teratogenic, carcinogenic, allergenic, or embryotoxic effects. Preclinical studies in laboratory animals have not revealed any negative effects on reproductive function or fetal development.
It exhibits anti-inflammatory properties in an experimental exudative edema model.

Indications for use
Herpesvirus infections of various localizations (including recurrent genital herpes, herpes zoster, and ophthalmic herpes).
Secondary immunodeficiency states due to infectious diseases.
Cytomegalovirus infection, including in patients with recurrent miscarriage. Used in women with chronic viral infections and interferon deficiency during pregnancy preparation.
Human papillomavirus infection (anogenital warts) as part of combination therapy.
Tick-borne encephalitis to reduce viral load and relieve neurological symptoms (anisoreflexia, decreased reflexes, tenderness at cranial nerve exit points, nystagmus) as part of combination therapy.
ARI and influenza as part of combination therapy.

Rectally.
For the treatment of herpesvirus infections and tick-borne encephalitis, take one suppository twice, 48 or 24 hours apart. If necessary, the treatment course can be repeated after one month.
For the treatment of cytomegalovirus and human papillomavirus infections, take one suppository three times during the first week, 48 hours apart, and twice during the second week, 72 hours apart.
For the treatment of acute respiratory viral infections and influenza, take one suppository every 24 hours for 5 days.